QQQ   420.30 (+1.36%)
AAPL   166.80 (+1.09%)
MSFT   402.00 (+0.72%)
META   485.24 (+0.87%)
GOOGL   157.04 (+1.91%)
AMZN   177.62 (+1.71%)
TSLA   142.49 (-3.10%)
NVDA   797.85 (+4.70%)
AMD   149.37 (+1.86%)
NIO   4.02 (+5.79%)
BABA   70.85 (+2.58%)
T   16.33 (-1.09%)
F   12.85 (+5.85%)
MU   109.98 (+3.01%)
GE   150.77 (+1.83%)
CGC   7.91 (-0.25%)
DIS   112.66 (+0.04%)
AMC   3.41 (+7.91%)
PFE   26.39 (+1.50%)
PYPL   63.42 (+1.78%)
XOM   121.04 (+0.97%)
QQQ   420.30 (+1.36%)
AAPL   166.80 (+1.09%)
MSFT   402.00 (+0.72%)
META   485.24 (+0.87%)
GOOGL   157.04 (+1.91%)
AMZN   177.62 (+1.71%)
TSLA   142.49 (-3.10%)
NVDA   797.85 (+4.70%)
AMD   149.37 (+1.86%)
NIO   4.02 (+5.79%)
BABA   70.85 (+2.58%)
T   16.33 (-1.09%)
F   12.85 (+5.85%)
MU   109.98 (+3.01%)
GE   150.77 (+1.83%)
CGC   7.91 (-0.25%)
DIS   112.66 (+0.04%)
AMC   3.41 (+7.91%)
PFE   26.39 (+1.50%)
PYPL   63.42 (+1.78%)
XOM   121.04 (+0.97%)
QQQ   420.30 (+1.36%)
AAPL   166.80 (+1.09%)
MSFT   402.00 (+0.72%)
META   485.24 (+0.87%)
GOOGL   157.04 (+1.91%)
AMZN   177.62 (+1.71%)
TSLA   142.49 (-3.10%)
NVDA   797.85 (+4.70%)
AMD   149.37 (+1.86%)
NIO   4.02 (+5.79%)
BABA   70.85 (+2.58%)
T   16.33 (-1.09%)
F   12.85 (+5.85%)
MU   109.98 (+3.01%)
GE   150.77 (+1.83%)
CGC   7.91 (-0.25%)
DIS   112.66 (+0.04%)
AMC   3.41 (+7.91%)
PFE   26.39 (+1.50%)
PYPL   63.42 (+1.78%)
XOM   121.04 (+0.97%)
QQQ   420.30 (+1.36%)
AAPL   166.80 (+1.09%)
MSFT   402.00 (+0.72%)
META   485.24 (+0.87%)
GOOGL   157.04 (+1.91%)
AMZN   177.62 (+1.71%)
TSLA   142.49 (-3.10%)
NVDA   797.85 (+4.70%)
AMD   149.37 (+1.86%)
NIO   4.02 (+5.79%)
BABA   70.85 (+2.58%)
T   16.33 (-1.09%)
F   12.85 (+5.85%)
MU   109.98 (+3.01%)
GE   150.77 (+1.83%)
CGC   7.91 (-0.25%)
DIS   112.66 (+0.04%)
AMC   3.41 (+7.91%)
PFE   26.39 (+1.50%)
PYPL   63.42 (+1.78%)
XOM   121.04 (+0.97%)
NASDAQ:CXRX

(CXRX) (CXRX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.19
$0.21
50-Day Range
$0.19
$0.19
52-Week Range
$0.19
$1.80
Volume
648,890 shs
Average Volume
267,843 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CXRX Stock News Headlines

Rangers aim to 'silence the crowd'
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
How will you remember Henderson?
Healthcare Takes A Big Step Forward With The Help Of AI
The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.
See More Headlines
Receive CXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CXRX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2016
Today
4/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CXRX
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Allan Oberman (Age 60)
    CEO & Director
  • Mr. Francesco Tallarico (Age 35)
    Chief Legal Officer & Sec.
  • Mr. Adrian A. de Saldanha (Age 57)
    Exec.
  • Mr. Adeel Ahmad (Age 44)
    Chief Financial Officer of Concordia International Segment
  • H.R.H. David J. Price (Age 55)
    Chief Financial Officer

CXRX Stock Analysis - Frequently Asked Questions

How were (CXRX)'s earnings last quarter?

(CXRX) (NASDAQ:CXRX) posted its quarterly earnings results on Friday, August, 12th. The company reported $1.38 earnings per share for the quarter, hitting the consensus estimate of $1.38. The firm had revenue of $231.70 million for the quarter, compared to the consensus estimate of $229.76 million. The company's revenue for the quarter was up 208.1% on a year-over-year basis.

What other stocks do shareholders of (CXRX) own?
This page (NASDAQ:CXRX) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners